Clinical Research Directory

Inclusion Criteria: * BMI ≥ 30 Kg/m2 * Patients scheduled to undergo a bariatric weight loss procedure (endoscopic or surgical) * Patients older than 18 years and younger than 75 years of age at time of consent * Patients able to provide written informed consent on the Institutional review board (IRB) approved informed consent form * Patients willing and able to comply with study requirements for follow-up Exclusion Criteria: * Any patient with BMI \< 30 Kg/m2 * Patients treated with intragastric balloons. * Pre-existing esophageal stenosis/stricture preventing advancement of an endoscope during screening/baseline Esophagogastroduodenoscopy (EGD) * Esophageal, gastric or duodenal malignancy * Severe medical comorbidities precluding endoscopy, or limiting life expectancy to less than 2 years in the judgment of the endoscopist * Uncontrolled coagulopathy or inability to be off anticoagulation or anti-platelet medication (ASA, Plavix) for 1 week prior to and 2 weeks after each endoscopy * Active fungal esophagitis * Known portal hypertension, visible esophageal or gastric varices, or history of esophageal varices * General poor health, multiple co-morbidities placing the patient at risk, or otherwise unsuitable for trial participation * Pregnant or planning to become pregnant during period of study participation * Patient refuses or is unable to provide written informed consent * Prior bariatric treatment procedure * Prior surgical or endoscopic anti-reflux procedure